Hepatic portal vein

Introduction: Extra-hepatic portal vein obstruction (EHPVO), i.e., in the absence of liver cirrhosis or abdominal cancer, is a rare manifestation of venous thrombosis that often leads to portal hypertension1.After prothrombin, factor V, next most common cause of thrombophilia is high plasma levels of coagulation factor VIII, which are present in approximately 20% of patients with deep vein thrombosis (DVT) of the lower limbs and increase the risk of the disease in a dose-dependent

Leonard 1031). The experiment compares the glucose concentration in the mesenteric arteries, the hepatic vein, and the hepatic portal vein before and after food consumption to establish the implication of the two hormones on the glucose levels. Mesenteric arteries carry the blood from the rest of the body to the intestines and have little glucose (Unger, Anna & Leonard 1033). Hepatic Portal Vein carries

connecting portal vein and the hepatic vein in order to relive vascular blood pleasure from the portal vein that can cause portal hypertension. Liver is an important organ in human body. It has several important functions. This includes, purifying blood by removing harmful substances, production of bile, and storage of nutrients. It also acts as a passage of blood from the spleen and the gastrointestinal tract to the inferior vena cava. Hepatic portal vein is the

Careful follow up and consistent monitoring are essential to ensure proper function of the portosystemic stent. While portal venography is excellent at demonstrating stent patency, Doppler ultrasound allows visualization of blood flow within the stent, portal system and hepatic venous system without the need for radiation and contrast injections. According to Boyer,23 TIPS dysfunction occurs in about 80% of treated patients. He suggests using Doppler ultrasound to assess the stent within 24 hours

of splenectomy on liver volume and function, and prognosis of cirrhosis in patients with esophageal varices. These studies were quite interesting considering my patient’s history of splenectomy, liver cirrhosis, and esophageal varices. Changes in hepatic function, splenic function, and liver volume were evaluated, as well as each patient’s probability of increased survival rate. Results showed that restoration of liver function accelerated over time once a splenectomy had been performed. No patient

ISSN 2320-5407 International Journal of Advanced Research (2015), Volume 3, Issue 12, 1539 – 1548 1539 Journal homepage: http://www.journalijar.com INTERNATIONAL JOURNAL OF ADVANCED RESEARCH RESEARCH ARTICLE Portal vein thrombosis in patients with liver cirrhosis Insights to risk factors, clinical presentation and outcome Afifi F. Afifi 1 , Usama M. Basha 1 , Fady M. Wadea 1 , Abdelaziz E. Samack 2 , Raghda A. Elsherbini 3 1- GIT and hepatology unit, internal medicine department, faculty of

What You Need to Know About Peripheral Vascular Disease Peripheral vascular disease (PVD) is a type of circulatory disorder that affects blood vessels in areas other than the heart or brain. Blood vessels that carry blood from the heart to the legs are most commonly affected. Blood vessels in the arms, kidneys, and stomach are also commonly affected. PVD is sometimes called peripheral arterial disease (PAD). There are two types of PVD: • Organic PVD. This is the more common type. It is caused

all › 41 Reads Download Add supplementary resources Recommend Portal vein thrombosis in patients with liver cirrhosis: insights to risk factors, clinical presentation and outcome Article in International Journal of Advanced Research 3(12):1539-1548 · December 2015 1st Afifi F Afifi 2nd Osama Basha 6.99 · Zagazig University + 1 3rd Fady Maher Zagazig University Last Raghda Abd Ellatif Hafez 16.2 · Faculty of medicine/Zagazig University.www.zu.edu.eg Show more authors 3 elements are still missing

Portal vein thrombosis in patients with liver cirrhosis: insights to risk factors, clinical presentation and outcome Afifi F. Afifi 1, Osama M. Basha 1 , Fady M. Wadea 1, Abdelaziz E. Samack 2, Raghda Abd-elatif Hafez 3 1- GIT and hepatology unit, Internal Medicine department, Faculty of Medicine, Zagazig University. 2- Radiology department, Faculty of Medicine, Zagazig University. 3- Microbiology&Immunology department, Faculty of Medicine, Zagazig University. EGYPT Manuscript Info Abstract

reported that cirrhotic patients with PVT had higher platelet level in comparison with cirrhotic patients without PVT and advanced stages of liver disease. From the previous results we can conclude that, in cirrhotic patients the impact of portal hypertension and deficiency of natural